Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
RepaGyn
- Development stage
- Unknown
- Lead developer
- FARMA-DERMA
- Modality
- Hydrogel Systems → Drug Delivery Systems, Device-based Delivery → Drug Delivery Systems
- Administration
- Vaginal
01
Overview
RepaGyn is a vaginal suppository formulated with sodium hyaluronate and several non-medicinal ingredients including aloe vera, centella asiatica, calendula officinalis, tea tree essential oil, semi-synthetic glycerides, and butylated hydroxytoluene (BHT). It is designed to relieve vaginal dryness and promote healing of the vaginal mucosa. The product is hormone-free and intended for use in cases of vaginal atrophy or dryness caused by menopause, stress, chemotherapy, or after invasive vaginal procedures. Each 2 g ovule contains 5 mg of sodium hyaluronate. RepaGyn has been used in several European countries for over a decade under various brand names[1][3][5].
- Brand names
- RepaGynCicatridineCicatridinaCikatridinaRepadina
- Other names
- RepaGyn Vaginal Suppositories
02
Targets
CD44 (CD44 antigen)ICAM1 (Intercellular Adhesion Molecule 1)LYVE1 (Lymphatic vessel endothelial hyaluronic acid receptor 1)RHAMM (Hyaluronan-mediated motility receptor)
Beyond the preview
Go deeper on RepaGyn.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on RepaGyn.